NEXGEL, Inc. (NXGLW) stock
NXGLWNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31Also trades as NXGL
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 17, 2026Score 6/3072% below fair value
$0.01+0.00 (0.00%)
Close on Oct 30, 2026Market cap $34.21MP/E –Yield –
Nexgel total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
Nexgel's total debt was $437.00K at Jun 30, 2026. For fiscal 2025 it was $489.00K, down 16.8% from the year before. The highest annual figure on record is $758.00K in fiscal 2023.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $489.00K | -16.8% |
| FY2024 | Dec 31, 2024 | $588.00K | -22.4% |
| FY2023 | Dec 31, 2023 | $758.00K | +182.8% |
| FY2022 | Dec 31, 2022 | $268.00K | +0.8% |
| FY2021 | Dec 31, 2021 | $266.00K | +3.9% |
| FY2020 | Dec 31, 2020 | $256.00K | – |
| FY2019 | Dec 31, 2019 | $0 | – |
Quarterly total debt
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $437.00K | -18.9% |
| Q1 FY2026 | Mar 31, 2026 | $463.00K | -17.8% |
| Q4 FY2025 | Dec 31, 2025 | $489.00K | -16.8% |
| Q3 FY2025 | Sep 30, 2025 | $515.00K | -47.0% |
| Q2 FY2025 | Jun 30, 2025 | $539.00K | -16.4% |
| Q1 FY2025 | Mar 31, 2025 | $563.00K | -15.1% |
| Q4 FY2024 | Dec 31, 2024 | $588.00K | -22.4% |
| Q3 FY2024 | Sep 30, 2024 | $971.00K | +167.5% |
| Q2 FY2024 | Jun 30, 2024 | $645.00K | +143.4% |
| Q1 FY2024 | Mar 31, 2024 | $663.00K | +149.2% |
| Q4 FY2023 | Dec 31, 2023 | $758.00K | +182.8% |
| Q3 FY2023 | Sep 30, 2023 | $363.00K | +34.9% |
| Q2 FY2023 | Jun 30, 2023 | $265.00K | +0.8% |
| Q1 FY2023 | Mar 31, 2023 | $266.00K | 0.0% |
| Q4 FY2022 | Dec 31, 2022 | $268.00K | +0.4% |
| Q3 FY2022 | Sep 30, 2022 | $269.00K | +6.3% |
| Q2 FY2022 | Jun 30, 2022 | $263.00K | +2.7% |
| Q4 FY2021 | Dec 31, 2021 | $266.00K | +3.9% |
| Q3 FY2021 | Sep 30, 2021 | $267.00K | +1.1% |
| Q2 FY2021 | Jun 30, 2021 | $253.00K | -2.7% |
| Q1 FY2021 | Mar 31, 2021 | $256.00K | – |
| Q4 FY2020 | Dec 31, 2020 | $256.00K | – |
| Q3 FY2020 | Sep 30, 2020 | $264.00K | – |
| Q2 FY2020 | Jun 30, 2020 | $260.00K | – |
| Q4 FY2019 | Dec 31, 2019 | $0 | – |